Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease,
amyotrophic lateral sclerosis, and multiple sclerosis are characterized by a chronic and …

The identification of activated T-lymphocytes restricted to myelin-derived immunogenic
peptides in multiple sclerosis (MS) and aquaporin-4 water channel in neuromyelitis optica …

Introduction Immunotherapies for multiple sclerosis (MS) significantly decrease the risk of
new relapses. However, the chronic compartmentalized inflammation and …

Neurodegenerative diseases, including Alzheimer disease (AD), Parkinson disease (PD),
multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and Huntington disease, are …

Background Patient heterogeneity poses significant challenges for managing individuals
and designing clinical trials, especially in complex diseases. Existing classifications rely on …

The visual system is one of the most accessible routes to study the central nervous system
under pathological conditions, such as in multiple sclerosis (MS). Non-invasive visual …

Multiple sclerosis (MS) is an autoimmune, neurodegenerative disease that is driven by
immune system-mediated demyelination of nerve axons. While diseases such as cancer …

The present meta-analysis was performed to assess the association between MS patients
and control subjects in terms of their circulating levels of arsenic (As), lead (Pb), mercury …

As of today, 20 disease-modifying drugs (DMDs) have been approved for the treatment of
relapsing multiple sclerosis (MS) and, based on their efficacy, they can be grouped into …

Dysregulation of signaling pathways in multiple sclerosis (MS) can be analyzed by
phosphoproteomics in peripheral blood mononuclear cells (PBMCs). We performed in vitro …